Automated Scale Reduction of Nonlinear QSP Models With an Illustrative Application to a Bone Biology System by Chihiro Hasegawa, Stephen B. Duffull

Connect to this object online.

Characterization of serotonin as a candidate biomarker of severity and prognosis of COVID-19 using LC/MS analysis by Kosuke Saito, Rika Ishikawa, Isao Kitamura, Kumiko Ogawa, Noriaki Arakawa, Yuchen Sun, Kazuo Imai, Takuya Maeda, Yoshiro Saito, Chihiro Hasegawa

Connect to this object online.

Serum stratifin and presepsin as candidate biomarkers for early detection of COVID-19 disease progression by Noriaki Arakawa, Shinichiro Matsuyama, Masaru Matsuoka, Isao Kitamura, Keiko Miyashita, Yutaro Kitagawa, Kazuo Imai, Kumiko Ogawa, Takuya Maeda, Yoshiro Saito, Chihiro Hasegawa

Connect to this object online.

A phase I, randomized, placebo‐controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID‐19 by Keisuke Nakamura, Katsukuni Fujimoto, Chihiro Hasegawa, Ikuo Aoki, Hiroyuki Yoshitsugu, Hiroyuki Ugai, Naoyoshi Yatsuzuka, Yoshiyuki Tanaka, Kenichi Furihata, Brian M. Maas, Prachi K. Wickremasingha, Kelly E. Duncan, Marian Iwamoto, Selwyn A. Stoch, Naoto Uemura

Connect to this object online.